The characteristics of patients with NVUGIB using antithrombotic drugs as compared with matched controls not using these drugs
| ATD (n = 202) | Control (n = 202) | P-value | |
|---|---|---|---|
| Age, years, median (IQR) | 72 (60–79) | 71 (60–79) | Equal by design |
| Charlson comorbidity score | 1 (1–2) | 1 (1–2) | Equal by design |
| Endoscopy score | 1 (0–2) | 1 (0–2) | Equal by design |
| Males | 125/202 (62%) | 105/202 (52%) | 0.06 |
| Smoking | 53/200 (27%) | 55/199 (28%) | 1.00 |
| Haemoglobin, g/dl | 10.3 (8.0–12.8) | 12.2 (9.4–13.8) | 0.02 |
| Urea, mmol/l | 9.8 (6.1–14.2) | 7.9 (5.5–12.5) | 0.04 |
| Blatchford score | 8 (4–11) | 5 (2–9) | <0.001 |
| Transfusion | 79/200 (40%) | 52/198 (26%) | 0.006 |